Baby food group Mead Johnson has extended its deal to source the DHA and ARA it uses in its infant formula from Martek Biosciences.
Under the terms of the agreement announced today (21 June), Martek will continue to be Mead Johnson’s global sole-source supplier of DHA and ARA for all of its infant formula products through to the end of 2015.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
“Mead Johnson pioneered the inclusion of DHA and ARA in infant formula in the United States,” said Dirk Hondmann, senior vice president – global research & development. “We continue to choose Martek as the supplier of these key ingredients because of their commitment to innovation and quality in technology and science.”
Martek has been supplying DHA and ARA to Mead Johnson for use in infant formula under a 25-year global license agreement executed in 1992.
Under the terms of the amended agreement, Martek will provide graduated price reductions to Mead Johnson over the period of the extension from this year. In addition, Mead Johnson has the option to add another four years to the extension beyond 2015.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
